Vax-Immune™ Chosen for Top 10 Most Promising Growth Companies at the Austin FUND Conference

HOUSTON - Oct. 27, 2018 - PRLog -- Vax-Immune^TM attended the FUND Conference held in Austin, Texas, on April 26 as an invited participant.  Vax-Immune was a top ten finalist at this national event. Over 100 companies introduced their products to an educated audience of investors.  The FUND Conference is a national connector with a focus on curated deal flow, bringing together emerging growth stage companies and entrepreneurs with VCs, angel investors, and industry experts.

    Vax-Immune presented its home-use LabReady^® proprietary diagnostic device. LabReady^® is an all in one device, allowing patients to collect their own culture, and know the results within minutes without leaving their home.

    According to Leonard E. Weisman, President and Chief Technology Officer, "Being a Top Ten finalist at the FUND Conference validates for us the interest our product, LabReady^® generates as a trailblazer in the future of home healthcare."

ABOUT VAX-IMMUNE, LLC

    Vax-Immune, based in Houston, Texas is led by a team of physicians, research scientists, business and financial leaders, marketing professionals and entrepreneurs, experienced in medical product development and commercialization. Vax-Immune has patents, and patents pending for their innovative solutions to rapidly diagnose, treat, and prevent infection.

    Vax-Immune's mission is to diagnose and treat infections anywhere, anytime, and in the process save lives and reduce costs.

    For further information, you can contact Dr. Weisman at 713.662.0077, or at info@vaximmune.com.  Learn more about Vax-Immune at http://www.vaximmune.com.